MicroRNAs and prostate cancer

Valeria Coppola, Ruggero De Maria, Désirée Bonci

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.

Original languageEnglish
JournalEndocrine-Related Cancer
Volume17
Issue number1
DOIs
Publication statusPublished - Mar 2010

Fingerprint

MicroRNAs
Prostatic Neoplasms
Tumor Suppressor Genes
Oncogenes
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Oncology

Cite this

MicroRNAs and prostate cancer. / Coppola, Valeria; De Maria, Ruggero; Bonci, Désirée.

In: Endocrine-Related Cancer, Vol. 17, No. 1, 03.2010.

Research output: Contribution to journalArticle

Coppola, Valeria ; De Maria, Ruggero ; Bonci, Désirée. / MicroRNAs and prostate cancer. In: Endocrine-Related Cancer. 2010 ; Vol. 17, No. 1.
@article{b0caf93dbe794f1f915394931cd17fd4,
title = "MicroRNAs and prostate cancer",
abstract = "Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.",
author = "Valeria Coppola and {De Maria}, Ruggero and D{\'e}sir{\'e}e Bonci",
year = "2010",
month = "3",
doi = "10.1677/ERC-09-0172",
language = "English",
volume = "17",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "BioScientifica Ltd.",
number = "1",

}

TY - JOUR

T1 - MicroRNAs and prostate cancer

AU - Coppola, Valeria

AU - De Maria, Ruggero

AU - Bonci, Désirée

PY - 2010/3

Y1 - 2010/3

N2 - Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.

AB - Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.

UR - http://www.scopus.com/inward/record.url?scp=77449157504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449157504&partnerID=8YFLogxK

U2 - 10.1677/ERC-09-0172

DO - 10.1677/ERC-09-0172

M3 - Article

C2 - 19779034

AN - SCOPUS:77449157504

VL - 17

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 1

ER -